DE69531722D1 - Karzinostatische Zusammensetzungen, welche Cis-Oxaliplatin und eine oder mehrere andere verträgliche Karzinostatika enthalten - Google Patents

Karzinostatische Zusammensetzungen, welche Cis-Oxaliplatin und eine oder mehrere andere verträgliche Karzinostatika enthalten

Info

Publication number
DE69531722D1
DE69531722D1 DE69531722T DE69531722T DE69531722D1 DE 69531722 D1 DE69531722 D1 DE 69531722D1 DE 69531722 T DE69531722 T DE 69531722T DE 69531722 T DE69531722 T DE 69531722T DE 69531722 D1 DE69531722 D1 DE 69531722D1
Authority
DE
Germany
Prior art keywords
carcinostats
oxaliplatin
compatible
compositions containing
containing cis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69531722T
Other languages
English (en)
Other versions
DE69531722T2 (de
Inventor
Masao Oguro
Junji Ohnishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Debiopharm SA
Original Assignee
Debiopharm SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP30301594A external-priority patent/JPH08136536A/ja
Priority claimed from JP33403594A external-priority patent/JPH08169825A/ja
Priority claimed from JP11636995A external-priority patent/JPH08291061A/ja
Application filed by Debiopharm SA filed Critical Debiopharm SA
Publication of DE69531722D1 publication Critical patent/DE69531722D1/de
Application granted granted Critical
Publication of DE69531722T2 publication Critical patent/DE69531722T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69531722T 1994-11-11 1995-11-10 Karzinostatische Zusammensetzungen, welche Cis-Oxaliplatin und eine oder mehrere andere verträgliche Karzinostatika enthalten Expired - Lifetime DE69531722T2 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP30301594A JPH08136536A (ja) 1994-11-11 1994-11-11 細胞分裂の観察方法及び抗癌剤の早期検定方法
JP30301594 1994-11-11
JP33403594A JPH08169825A (ja) 1994-12-15 1994-12-15 抗癌剤の併用投与方法及び併用可能な抗癌剤
JP33403594 1994-12-15
JP11636995 1995-04-18
JP11636995A JPH08291061A (ja) 1995-04-18 1995-04-18 抗癌剤の併用投与方法及び併用可能な抗癌剤

Publications (2)

Publication Number Publication Date
DE69531722D1 true DE69531722D1 (de) 2003-10-16
DE69531722T2 DE69531722T2 (de) 2004-07-01

Family

ID=27313136

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69531722T Expired - Lifetime DE69531722T2 (de) 1994-11-11 1995-11-10 Karzinostatische Zusammensetzungen, welche Cis-Oxaliplatin und eine oder mehrere andere verträgliche Karzinostatika enthalten

Country Status (5)

Country Link
US (2) US6518278B1 (de)
EP (2) EP0715854B1 (de)
DE (1) DE69531722T2 (de)
ES (1) ES2206478T3 (de)
HK (1) HK1063004A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804013D0 (en) * 1998-02-25 1998-04-22 Sanofi Sa Formulations
US6545010B2 (en) 2000-03-17 2003-04-08 Aventis Pharma S.A. Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer
US6476068B1 (en) 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
WO2004087105A1 (en) * 2003-04-02 2004-10-14 Celator Pharmaceuticals, Inc. Combination formulations of platinum agents and fluoropyrimidines
WO2005051966A1 (en) 2003-11-25 2005-06-09 Platco Technologies (Proprietary) Limited Platinum(ii) complexes, preparation and use
ATE514706T1 (de) 2004-09-01 2011-07-15 Platco Technologies Proprietary Ltd Herstellung von platin (ii)-komplexen
EP1827437B1 (de) 2004-12-15 2011-11-02 Novartis AG Kombinationen von therapeutischen wirkstoffen zur krebsbehandlung
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
RU2008135369A (ru) 2006-01-30 2010-03-10 Платко Текнолоджис (Проприэтэри) Лимитед (Za) Получение комплексов платины(ii)
EP2094268A2 (de) * 2006-05-26 2009-09-02 Bayer HealthCare, LLC Arzneikombinationen mit substituierten diaryl-harnstoffen zur krebsbehandlung
ATE530188T1 (de) 2007-03-02 2011-11-15 Univ Wollongong Zusammensetzungen und verfahren zur abgabe von mitteln gegen krebs
TWI468188B (zh) * 2008-01-30 2015-01-11 Univ Tokushima Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
WO2009139085A1 (ja) * 2008-05-12 2009-11-19 静岡県 抗腫瘍剤、キット及び癌治療方法
FR3035729B1 (fr) 2015-04-28 2020-11-27 Ateme Procede d'analyse d'une sequence video et equipement pour la mise en oeuvre du procede

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE247471T1 (de) * 1991-11-15 2003-09-15 Smithkline Beecham Corp Cisplatin und topotecan enthaltende zusammensetzung als antitumor.
WO1994012193A1 (fr) * 1992-11-24 1994-06-09 Debiopharm S.A. Combinaison de cisplatine avec l'oxaliplatine

Also Published As

Publication number Publication date
HK1063004A1 (en) 2004-12-10
EP1369116A1 (de) 2003-12-10
EP0715854A3 (de) 1999-09-01
EP0715854A2 (de) 1996-06-12
US6518278B1 (en) 2003-02-11
ES2206478T3 (es) 2004-05-16
US20040005365A1 (en) 2004-01-08
EP0715854B1 (de) 2003-09-10
DE69531722T2 (de) 2004-07-01

Similar Documents

Publication Publication Date Title
DE3575296D1 (de) Pyrazolkarboxamidabkoemmlinge, deren herstellung und diese enthaltende bakterientoetende mittel.
DE69021129D1 (de) Bleichaktivierung und Bleichmittel-Zusammensetzungen.
IL113410A0 (en) Substituted sulfonamides their use and pharmaceutical compositions containing them
DE69210994D1 (de) Nichtazeotropische zusammensetzungen die difluormethan, 1,1,1-trifluorethan undpropan enthalten
IT8821134A0 (it) Frazioni oligomeriche procianidoliche, loro procedimentodi preparazione e composizioni farmaceutiche che le contengono.
DE69601765D1 (de) Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten
DE68912237D1 (de) Dampfsensitive Zusammensetzung sowie diese enthaltende sterilisierungsanzeigende Zusammensetzung.
EP0611302A4 (de) Verfahren und zusammensetzungen zur behandlung von allergischen reaktionen.
DE3579452D1 (de) Geschwefelte zusammensetzungen und schmiermittel.
DE69531722D1 (de) Karzinostatische Zusammensetzungen, welche Cis-Oxaliplatin und eine oder mehrere andere verträgliche Karzinostatika enthalten
BR8904519A (pt) Composicao fungicida,processos para preparar compostos fungicidas e para preparar compostos de benzoilacetonitrila
ATE47853T1 (de) 5,6-difluornaphtyridine und 5,6,8trifluorchinoline verwendbar als antibakterielle mittel.
DE68910113D1 (de) Wachstuminhibierendes mittel und dessen verwendung.
DE3780708D1 (de) Copolyester und zusammensetzungen die diesen enthalten.
EP0366753A4 (de) N-alkoxyalkylamide und kosmetische behandlungszusammensetzungen.
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
KR960705557A (ko) 항미생물 방법 및 화장품 조성물(antimicrobial method and cosmetic composition)
GB9504040D0 (en) Arylsulfonamide derivative and pharmaceutical composition containing the same
DE69002520D1 (de) Azeotropaehnliche zusammensetzungen von 1,1-dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1-fluoraethan.
ATE90510T1 (de) Antimikrobische zusammensetzung und deren verwendung.
DE68905973D1 (de) Synergistische suessungsmittel-zusammensetzungen, enthaltend chlorodeoxysucrase, und diese enthaltende zusammensetzungen.
DE3878774D1 (de) Paraherquamid und dihydroparaherquamid als antiparasitaere mittel.
EP0612840A3 (de) Cyclische Verbindungen und ihre Anwendung als Riechstoffe.
IL91851A0 (en) Antimicrobial compositions containing 2,2-dibromo-2-nitroethanol and methods for killing microorganisms utilizing the same
IT8747783A0 (it) Fiammenghi e domenighetti fiammenghi - via quattro fontane, 31 roma

Legal Events

Date Code Title Description
8364 No opposition during term of opposition